fingolimod hydrochloride has been researched along with myelin basic protein in 9 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (myelin basic protein) | Trials (myelin basic protein) | Recent Studies (post-2010) (myelin basic protein) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 7,478 | 78 | 1,278 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, K; Fukunari, A; Kataoka, H; Koyama, M; Shimano, K; Sugahara, K; Teshima, K | 1 |
| Barske, C; Bouhelal, R; Dev, KK; Dubois, C; Gasparini, F; Guerini, D; Haessig, S; Mattes, H; Mir, AK; Orain, D; Osinde, M; Picard, A; Tasdelen, E | 1 |
| Fontoura, P; Garren, H | 1 |
| Baker, D; Giovannoni, G; Jackson, SJ | 1 |
| Dev, KK; Sheridan, GK | 1 |
| Brieland, JK; Chen, YJ; Kim, JH; O'Neal, J; O'Neil, SP; Song, SK; Trinkaus, K; Tu, TW; Wang, X | 1 |
| Bail, K; Bharti, R; Foerstner, KU; Kleinschnitz, C; Koeniger, T; Kuerten, S; Notz, Q; Rovituso, DM; Schampel, A; Scholz, CJ; Schropp, V; Wunsch, M | 1 |
| Chen, M; Kurniawan, ND; Meyer-Schell, N; Reutens, D; Sullivan, R; Vegh, V; Ziser, L | 1 |
| Alasmari, AF; Alharbi, M; Alshammari, A; Assiri, MA; Kalfin, R; Kapoor, T; Kumar, N; Mehan, S; Narula, AS; Sharma, N; Suri, M | 1 |
1 review(s) available for fingolimod hydrochloride and myelin basic protein
| Article | Year |
|---|---|
Multiple sclerosis therapies: molecular mechanisms and future.
Topics: Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Cladribine; Crotonates; Daclizumab; Dimethyl Fumarate; Encephalomyelitis, Autoimmune, Experimental; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Immunoglobulin G; Immunosuppressive Agents; Immunotherapy; Mice; Multiple Sclerosis; Myelin Basic Protein; Nitriles; Peptide Fragments; Propylene Glycols; Quinolones; Rituximab; Sphingosine; Toluidines; Vaccines, DNA | 2010 |
8 other study(ies) available for fingolimod hydrochloride and myelin basic protein
| Article | Year |
|---|---|
FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration.
Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Fingolimod Hydrochloride; Glycoproteins; Male; Mice; Myelin Basic Protein; Myelin Proteolipid Protein; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Propylene Glycols; Rats; Receptors, Lysosphingolipid; Sphingosine; T-Lymphocytes | 2005 |
Design and synthesis of selective and potent orally active S1P5 agonists.
Topics: Administration, Oral; Amino Acid Sequence; Animals; Binding Sites; Computer Simulation; Drug Design; Fingolimod Hydrochloride; Molecular Sequence Data; Myelin Basic Protein; Oligodendroglia; Phthalazines; Propylene Glycols; Rats; Receptors, Lysosphingolipid; Sphingosine; Structure-Activity Relationship | 2010 |
Fingolimod modulates microglial activation to augment markers of remyelination.
Topics: Animals; Biomarkers; Cell Culture Techniques; Cells, Cultured; Demyelinating Diseases; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lysophosphatidylcholines; Microglia; Multiple Sclerosis, Relapsing-Remitting; Myelin Basic Protein; Myelin Sheath; Nerve Degeneration; Pregnancy; Propylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Spheroids, Cellular; Sphingosine | 2011 |
S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures.
Topics: Animals; Animals, Newborn; Astrocytes; Cell Movement; Cerebellum; Chemokine CCL20; Chemokine CCL3; Chemokines; Demyelinating Diseases; Fingolimod Hydrochloride; Gene Expression Regulation; Immunosuppressive Agents; Lysophosphatidylcholines; Myelin Basic Protein; Neurofilament Proteins; Organ Culture Techniques; Oxadiazoles; Propylene Glycols; Rats; Rats, Wistar; Receptors, Lysosphingolipid; Sphingosine; Thiophenes | 2012 |
Diffusion tensor imaging detects treatment effects of FTY720 in experimental autoimmune encephalomyelitis mice.
Topics: Animals; Anisotropy; Diffusion Tensor Imaging; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Fingolimod Hydrochloride; Mice; Mice, Inbred C57BL; Myelin Basic Protein; Propylene Glycols; Sphingosine; Spine | 2013 |
Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis.
Topics: Animals; Antigens, CD19; B-Lymphocytes; Calcium-Binding Proteins; CD4-Positive T-Lymphocytes; Cell Aggregation; Central Nervous System; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunospot Assay; Female; Fingolimod Hydrochloride; Flow Cytometry; Freund's Adjuvant; Immunosuppressive Agents; Lymph Nodes; Mice; Myelin Basic Protein; Myelin Proteolipid Protein; Recombinant Fusion Proteins; Spleen; Time Factors | 2017 |
Utility of gradient recalled echo magnetic resonance imaging for the study of myelination in cuprizone mice treated with fingolimod.
Topics: Animals; Cuprizone; Fingolimod Hydrochloride; Gray Matter; Magnetic Resonance Imaging; Mice; Microglia; Myelin Basic Protein; Myelin Sheath; Parvalbumins | 2018 |
Forskolin, an Adenylcyclase/cAMP/CREB Signaling Activator Restoring Myelin-Associated Oligodendrocyte Destruction in Experimental Ethidium Bromide Model of Multiple Sclerosis.
Topics: Adenylyl Cyclases; Animals; Colforsin; Cytokines; Demyelinating Diseases; Donepezil; Ethidium; Fingolimod Hydrochloride; Gliotoxin; Memantine; Multiple Sclerosis; Myelin Basic Protein; Myelin Sheath; Nerve Growth Factors; Neurodegenerative Diseases; Oligodendroglia; Rats; Rats, Wistar; Simvastatin | 2022 |